http://youtu.be/yu01h7KD-EI I
use to promote ZNZ One zipnadazilch but i stopped because i was working
long hours day and night none stop, was making good money but didn't
really have time for nothing the reason i started doing this online
stuff is to have freedom you know? Like go on vacations spend time
withe family and friends.. but with ZNZ i couldn't do none of that and
that's why i stop promoting it, but this is just my ZNZ review, my
opinion.
The holiday season is the most wonderful time of the year. Gifts are perfectly wrapped, cakes and cookies are baking in the oven, and people across the country are making final preparations to visit their loved loves. In fact, Americans spent an average of 7.3 hours and $560 on holiday travel alone last year, which can also lead to chaos, stress and precious time spent in busy airports and jam-packed highways. That’s why Ziploc® brand is offering a variety of festive products, a surprise-and-delight experience and helpful tips to give travelers a chaos-free holiday.
When hundreds of people along the Ohio Turnpike got to the tollbooth at Mile Marker 71 before their Thanksgiving celebrations began, they were surprised that instead of being asked for the toll, they received an array of gifts—from snacks packed in Ziploc® brand bags and containers to a chauffeured limo ride home.
To view the multimedia release go to:
http://www.multivu.com/players/English/7707651-ziploc-chaos-free-holiday/
Zero Gravity raised $665.00 for charity by jumping into the frozen waters of Crystal Lake on February 28th, 2009. Zero Gravity is a sportbike community in Minnesota. Check out www.teamzg.com for more info!
Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun’s innovative “first-in-class” anti-heart failure drug, Neucardin™.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61677-zensun-completes-clinical-trials-of-neucardin-treatment-of-heart-failure
Like any third grade boy, Zeke Meeks has his share of problems. His little sister sings embarrassing princess songs around his friends. He has a deep, dark secret that no one can find out about. Psst, he is terrified of bugs! And his biggest enemy is a tiny, evil girl with razor sharp fingernails. It is Zeke Meeks versus the world! Learn more about the book and author here, http://bit.ly/pEvolz and here, http://bit.ly/qapTBi Children’s Fiction
Watch the #partyanimals fall for a big smile. Who's In? Get your night out sorted with http://thehowlapp.com. Or hit http://Facebook.com/JoseCuervo for all things tequila.
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
zNitro (znitro.com), a Clear Protector company, today announced it will launch its exclusive lineup of Nitro electronics accessories at the Macworld/iWorld Show 2013. zNitro will be located at Booth 809 in the Moscone Center of this gala San Francisco event scheduled for January 31- February 2, 2013.
Building on the exceptional reputation for quality established by its Clear Protector predecessor, zNitro will continue to offer outstanding value and top-of-the-line products for consumers.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59895-former-clear-protector-znitro-mobile-electronic-devices-accessories
